Education
M.Sc. in Economics from Aalborg University, Denmark
Other assignments
Chairman of the Board of Directors at StemMedical, SSI Diagnostica, Union Therapeutics and Moksha8. Member of the Board of Directors of TAP, Skybrands, BroenLab, Hasle Refractories, NLS Pharmaceutics and Quiapeg. In addition, Stig is Operating Partner in the private equity fund Catacap.
Experience and prior assignments
More than 35 years of strategic, commercial and leadership expertise from the life science industry, holding senior positions at H. Lundbeck and Ciba-Geigy (now Novartis).
Education
MD, Linköping University (1989), Specialist in Neurology (1993), Specialist in Clinical Chemistry (1999), PhD, Linköping University (1999), Associate professor, Linköping University (2012), Sweden
Other assignments
Since 2002, member of the Steering Board of the Swedish Movement Disorder Society, SWEMODIS, affiliated to the International Parkinson and Movement Disorder Society, MDS. Founding member of the Scandinavian Movement Disorder Society, Scandmodis. Since 2009, she is also member (and founding member) of the steering board of the Swedish National Network for Parkinson Research, SWEPAR-Net
Experience and prior assignments
More than 25 years of experience from Neurology. She is also specialist in Clinical Chemistry and started her research on Malignant melanoma and later on Parkinson’s disease. The knowledge from both these fields led to the development of the first Infudopa™ formulation for intravenous use. She is one of the founders of Dizlin Pharmaceuticals AB.
Education
Master of Law from Lund University, Sweden
Other assignments
Partner of the business law firm HWF Advokater AB in Helsingborg. Board member of Proventus Capital Management AB
Experience and prior assignments
Previously a partner of Mannheimer Swartling Advokatbyrå where she was active since 2001, whereby 2009–2011 in Russia, before co-founding HWF in 2018. She operates within public and private M&A, equity capital markets law and corporate commercial matters for listed and non-listed companies. Industry sectors include chemicals, health care and life sciences and industrials.
Education
BA Hons Business Administration from the London Guildhall University, United Kingdom
Other assignments
CEO and Member of the Board of Directors of the ESTEVE Group. Member of the Board of Directors of Swedish Orphan Biovitrum AB (SOBI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and Corporacíon Químico Farmacéutical Esteve S.A.
Experience and prior assignments
More than 20 years of experience from board and executive management roles, including a number of senior positions within Lundbeck A/S, such as Regional Vice President for Southern and Western Europe, President and Chairman of the U.S. Operations and Global Chief Commercial Officer on Group level.
Education
MBA from School of Business, Economics and Law at University of Gothenburg, Sweden
Other assignments
Managing Director of CampusPharma AB
Experience and prior assignments
More than 25 years of experience from the pharmaceutical industry. Since 2004, he is the co-founder, co-owner and Managing Director of CampusPharma AB.